Everolimus

Introduction Everolimus is an oral mammalian target of rapamycin inhibitor, commonly called an mTOR inhibitor. It is used as an anticancer drug, immunosuppressant, and targeted therapy in selected genetic and proliferative disorders. It is marketed under different brand names depending on indication, such as Afinitor for oncology and tuberous sclerosis complex-related conditions, and Zortress for … Read more